Disclosures for "Leveraging MHConstructor to Uncover Structural Variation in the MHC in Alzheimer’s Disease"
-
Miss Stewart has nothing to disclose.
-
Dr. Wade has nothing to disclose.
-
Ms. Oddi has nothing to disclose.
-
Dr. Piña Escudero has nothing to disclose.
-
Prof. Hollenbach has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for HLA journal.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Dr. Bruno has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Custodio Capunay has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Dr. Zapata-Restrepo has nothing to disclose.
-
Dr. Miller has nothing to disclose.
-
An immediate family member of Dr. Nalls has received personal compensation for serving as an employee of Valo Health. The institution of Dr. Nalls has received personal compensation in the range of $1,000,000+ for serving as a Consultant for DataTecnica. Dr. Nalls has stock in Neuron23 and Character Bio. The institution of Dr. Nalls has received research support from US govt, various NPO and Commercial. Dr. Nalls has received intellectual property interests from a discovery or technology relating to health care.
-
An immediate family member of Andrew Singleton has received personal compensation for serving as an employee of GeneDx. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Partner Journals Parkinson Disease. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. An immediate family member of Andrew Singleton has stock in GeneDx. The institution of Andrew Singleton has received research support from Michael J Fox Foundation. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care.
-
Author has nothing to disclose
-
The institution of Dr. Cochran has received research support from NIH. The institution of Dr. Cochran has received research support from Alzheimer's Association. The institution of Dr. Cochran has received research support from Rainwater Charitable Foundation.
-
Mr. Taylor has nothing to disclose.
-
Dr. Valcour has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for IAS-USA. Dr. Valcour has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.
-
Author has nothing to disclose
-
The institution of Dr. Yokoyama has received research support from NIH. The institution of Dr. Yokoyama has received research support from Alzheimer's Association . The institution of Dr. Yokoyama has received research support from Mary Oakley Foundation. The institution of Dr. Yokoyama has received research support from Alector. The institution of Dr. Yokoyama has received research support from Transposon. The institution of Dr. Yokoyama has received research support from Rainwater Charitable Foundation.